Five-Year Survival of Stage IIIA-IIIB (Non-N3) Non-Small Cell Lung Cancer Patients after Platinum/Gemcitabine Induction Chemotherapy and Surgery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Five-Year Survival of Stage IIIA-IIIB (Non-N3) Non-Small Cell Lung Cancer Patients after Platinum/Gemcitabine Induction Chemotherapy and Surgery

Published:2010-06 Issue:3 Volume:22 Page:191-196
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Imperatori A.,La Salvia D.,Rotolo N.,Nardecchia E.,Bandera M.,Toungoussova O.,Spanevello A.,Dominioni Dominioni

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference14 articles.

1. Development of gemcitabine in non-small cell lung cancer: the Italian contribution

2. Revisions in the International System for Staging Lung Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal Extent of Neck Dissection for a Head and Neck Lymph Node Metastasis from a Remote Primary Site;Journal of Clinical Medicine;2024-01-23

2. The Proposition of the Pulmonary Route as an Attractive Drug Delivery Approach of Nano-Based Immune Therapies and Cancer Vaccines to Treat Lung Tumors;Frontiers in Nanotechnology;2021-03-04

3. Association of PTEN Gene SNPs rs2299939 With PFS in Patients With Small Cell Lung Cancer Treated With Early Radiotherapy;Frontiers in Genetics;2020-04-23

4. Comparison of seventh TNM and eighth TNM staging system in stage III non–small cell lung cancer patients treated with concurrent chemoradiotherapy;Current Problems in Cancer;2019-02

5. Gemcitabine-loaded gold nanospheres mediated by albumin for enhanced anti-tumor activity combining with CT imaging;Materials Science and Engineering: C;2018-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3